Immediate Office
|
 |
|
Robin Robinson, Ph.D.
Director |
|
 |
|
Carol D. Linden, Ph.D.
Principal Deputy Director |
 |
|
Richard J. Hatchett, M.D.
Chief Medical Officer &
Deputy Director for Strategic Sciences |
|
|
|
|
Influenza and Emerging Diseases Division
|
 |
|
Robert (Bob) Huebner, Ph.D.
Acting Director |
|
 |
|
R. Thomas Warf, M.S.
Product Process Development Analysis |
Division of Chemical, Biological, Radiological, and Nuclear (CBRN) Countermeasures
|
 |
|
Gerald R. Kovacs, Ph.D.
Director |
|
 |
|
Gary L. Disbrow, Ph.D.
Deputy Director |
Strategic Science and Technology Division
|
 |
|
Jonathan Seals, Ph.D.
Acting Director |
|
|
|
|
Regulatory and Quality Affairs Division
|
 |
|
Debra Yeskey, Pharm.D.
Director |
|
|
|
|